Physician profile
Kevin Lee
NPI 1306405030
$12,095.81
in general payments reported to CMS, 2019-2025
31 companies · $3,237 in 2025
The $3,237 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,678 · 2022: $1,634 · 2023: $2,060 · 2024: $3,487 · 2025: $3,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,901 · Education: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,901.31 |
| Education | $882.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,263.49 | 2021-2025 | |
| Incyte Corporation | $1,190.80 | 2021-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $1,084.88 | 2021-2025 | Tremfya, Stelara, Simponi |
| Regeneron Healthcare Solutions, INC. | $1,068.52 | 2021-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $904.50 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Sun Pharmaceutical Industries INC. | $808.47 | 2021-2025 | Ilumya, Winlevi, Odomzo |
| Amgen INC. | $661.50 | 2021-2025 | Otezla, Otezla |
| Genzyme Corporation | $619.25 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $585.89 | 2021-2025 | |
| Leo Pharma INC. | $541.04 | 2021-2025 | Adbry, Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $496.60 | 2021-2025 | Cabtreo, Jublia, Arazlo |
| Ucb, INC. | $435.58 | 2021-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $421.97 | 2021-2025 | Nemluvio |
| Dermavant Sciences, INC. | $348.65 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $339.67 | 2023-2025 | Zoryve |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $330.52 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $268.38 | 2022-2025 | Sotyktu |
| Epi Health, LLC | $153.32 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $143.21 | 2022-2023 | |
| Organon LLC | $89.72 | 2025 | Vtama, Nexplanon |
| Journey Medical Corporation | $65.12 | 2022-2023 | |
| Vyne Pharmaceuticals INC. | $61.43 | 2021 | |
| Strata Skin Sciences, INC. | $50.31 | 2024-2025 | Xtrac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.89 | 2022-2023 | Spevigo |
| Almirall LLC | $28.89 | 2022 | |
| Nabriva Therapeutics, Plc | $26.93 | 2022 | |
| Polarityte, INC. | $17.20 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.64 | 2024 | Simlandi |
| Biofrontera INC. | $15.00 | 2021 | |
| Ani Pharmaceuticals, INC. | $14.91 | 2025 | Purified Cortrophin Gel |
| Kyowa Kirin, INC. | $14.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.